[<sup>18</sup>F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31822959.
- Also identified by DOI 10.1007/s00259-019-04614-y.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [<sup>18</sup>F]Fluciclovine PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of [<sup>18</sup>F]Fluciclovine PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.
Medical subject headings
- Cyclobutanes
- Prostatic Neoplasms